VNDA
Vanda Pharmaceuticals Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report4 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+1.25%
vs ±11.7% implied · ×0.11
shaded = implied · ▲▼ = realized
No thesis.
Vanda Pharmaceuticals Inc.
3.79
Fund move
Fund move
No implied move.
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $46.8M | 15.33% | +5.19% | |
| 2 | State StreetState Streetindex-like | $21.5M | 7.05% | +16.61% | |
| 3 | AQR Capital ManagementAQR | $21.4M | 7.01% | +118.12% | |
| 4 | Renaissance TechnologiesRenaissance Technologies | $21.1M | 6.89% | −8.46% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $15.4M | 5.06% | +1.71% | |
| 6 | AIGH Capital ManagementAIGH | $12.5M | 4.10% | −25.67% | |
| 7 | Acadian Asset ManagementAcadian | $11.7M | 3.84% | +6.82% | |
| 8 | Dimensional Fund AdvisorsDimensional | $10.6M | 3.46% | −2.50% | |
| 9 | Millennium ManagementMillennium | $9.8M | 3.21% | −14.79% | |
| 10 | Geode Capital ManagementGeodeindex-like | $9.1M | 2.97% | +2.83% | |
| 11 | Two Sigma InvestmentsTwo Sigma | $8.3M | 2.70% | −3.51% | |
| 12 | Marshall WaceMarshall Wace | $7.5M | 2.46% | +105.70% | |
| 13 | Jacobs Levy Equity ManagementJacobs Levy Equity | $7.4M | 2.43% | +3.82% | |
| 14 | Krensavage Asset ManagementKrensavage | $7.2M | 2.36% | 0.00% | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $6.9M | 2.27% | +11.48% | |
| 16 | Goldman Sachs GroupGoldman Sachs | $6.3M | 2.08% | +23.62% | |
| 17 | Citadel AdvisorsCitadel | $5.2M | 1.70% | +3.05% | |
| 18 | Qube Research & TechnologiesQube Research & Technologies | $4.5M | 1.46% | new | |
| 19 | Federated InvestorsFederated Investors | $4.4M | 1.43% | +24.14% | |
| 20 | Charles Schwab Investment ManagementCharles Schwabindex-like | $4.0M | 1.29% | +17.12% | |
| 21 | Northern TrustNorthern Trustindex-like | $3.7M | 1.20% | +33.18% | |
| 22 | Morgan StanleyMorgan Stanley | $2.9M | 0.96% | +8.43% | |
| 23 | Lionhunter Capital ManagementLionhunter | $2.4M | 0.80% | — | |
| 24 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.4M | 0.80% | new | |
| 25 | Jump FinancialJump Financial | $2.1M | 0.68% | +70.92% |
172 managers report $305.5M of Vanda Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; BlackRock is largest at 15.33%.
Expected move
No implied move.
Linked news